These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36517053)

  • 1. Effect of gut microbiota on colorectal cancer progression and treatment.
    Alasiri GA
    Saudi Med J; 2022 Dec; 43(12):1289-1299. PubMed ID: 36517053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal Cancer in Inflammatory Bowel Disease: A Review of the Role of Gut Microbiota and Bacterial Biofilms in Disease Pathogenesis.
    Muñiz Pedrogo DA; Sears CL; Melia JMP
    J Crohns Colitis; 2024 Oct; 18(10):1713-1725. PubMed ID: 38703073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and inflammatory bowel disease.
    Chen L; Wang J
    WIREs Mech Dis; 2022 Mar; 14(2):e1540. PubMed ID: 35266651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond bacteria: Role of non-bacterial gut microbiota species in inflammatory bowel disease and colorectal cancer progression.
    Haque H; Zehra SW; Shahzaib M; Abbas S; Jaffar N
    World J Gastroenterol; 2024 Sep; 30(36):4078-4082. PubMed ID: 39351246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
    Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
    Front Immunol; 2021; 12():612826. PubMed ID: 33841394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in colorectal cancer development and therapy.
    Wong CC; Yu J
    Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles derived from gut microbiota in inflammatory bowel disease and colorectal cancer.
    Alberti G; Mazzola M; Gagliardo C; Pitruzzella A; Fucarini A; Giammanco M; Tomasello G; Carini F
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Sep; 165(3):233-240. PubMed ID: 34282804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
    Kong F; Cai Y
    Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders.
    Islam MR; Arthur S; Haynes J; Butts MR; Nepal N; Sundaram U
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbe-based therapies for colorectal cancer: Advantages and limitations.
    Saeed M; Shoaib A; Kandimalla R; Javed S; Almatroudi A; Gupta R; Aqil F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):652-665. PubMed ID: 34020027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Wong SH; Yu J
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer.
    Gu M; Yin W; Zhang J; Yin J; Tang X; Ling J; Tang Z; Yin W; Wang X; Ni Q; Zhu Y; Chen T
    Front Cell Infect Microbiol; 2023; 13():1119992. PubMed ID: 37265504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of gut microbes and its metabolites in colorectal cancer.
    Kumar A; Ali A; Kapardar RK; Dar GM; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Mahajan B; Saluja SS
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):441-465. PubMed ID: 36572792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut barrier as a gatekeeper in colorectal cancer treatment.
    Hajjar R; Richard C; Santos MM
    Oncotarget; 2024 Aug; 15():562-572. PubMed ID: 39145528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease.
    Lopez LR; Ahn JH; Alves T; Arthur JC
    Front Cell Infect Microbiol; 2022; 12():934619. PubMed ID: 35959366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome-phage interactions in inflammatory bowel disease.
    Federici S; Kviatcovsky D; Valdés-Mas R; Elinav E
    Clin Microbiol Infect; 2023 Jun; 29(6):682-688. PubMed ID: 36191844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and microbiota-derived metabolites in colorectal cancer: enemy or friend.
    Wang X; Sun X; Chu J; Sun W; Yan S; Wang Y
    World J Microbiol Biotechnol; 2023 Sep; 39(11):291. PubMed ID: 37653349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.